SNP ID | Position | Alleles | Trait | Variation Type |
---|---|---|---|---|
rs1757321 | chr9:121569480 (GRCh38.p7) | C>T | alcohol dependence | SNV(Single Nucleotide Variation) |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
NACC1 | 0.917 |
PRRC2A | 0.909 |
BAP1 | 0.906 |
TNPO2 | 0.906 |
TRAF7 | 0.905 |
RAPGEF1 | 0.904 |
PPP6R1 | 0.901 |
DLGAP4 | 0.9 |
SCMH1 | 0.898 |
GNA11 | 0.895 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
OR4F5 | -0.739 |
OR4F29 | -0.698 |
ANXA13 | -0.372 |
CTNNA3 | -0.356 |
SH2D1A | -0.347 |
DTHD1 | -0.332 |
SGMS2 | -0.327 |
FXYD4 | -0.317 |
C5orf64 | -0.314 |
TMEM139 | -0.314 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of DAB2IP mRNA | 19933214 |
C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of DAB2IP mRNA" | 21346803 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased methylation of DAB2IP gene | 27153756 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of DAB2IP mRNA | 16483693 |
D018501 | Antirheumatic Agents | Antirheumatic Agents results in increased expression of DAB2IP mRNA | 24449571 |
C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of DAB2IP mRNA | 22521957 |
D001280 | Atrazine | Atrazine results in decreased expression of DAB2IP mRNA | 25929836 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of DAB2IP mRNA | 19770486 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of DAB2IP mRNA | 22228805 |
C006780 | bisphenol A | bisphenol A results in increased expression of DAB2IP mRNA | 27685785 |
C006780 | bisphenol A | bisphenol A affects the expression of DAB2IP mRNA | 25181051 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of DAB2IP mRNA | 26472689 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of DAB2IP mRNA | 17484886 |
C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of DAB2IP mRNA | 19320972 |
D003042 | Cocaine | Cocaine results in decreased expression of DAB2IP mRNA | 17898221 |
D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of DAB2IP mRNA | 19549813 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of DAB2IP mRNA | 25562108 |
D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in increased expression of DAB2IP mRNA | 27392435 |
D002945 | Cisplatin | Cisplatin results in increased expression of DAB2IP mRNA | 27392435 |
C000944 | dicrotophos | dicrotophos results in increased expression of DAB2IP mRNA | 28302478 |
D002117 | Calcitriol | Calcitriol results in decreased expression of DAB2IP mRNA | 16002434 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of DAB2IP mRNA | 18936297 |
C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in increased expression of DAB2IP mRNA | 27392435 |
D007657 | Ketone Bodies | Ketone Bodies results in decreased expression of DAB2IP mRNA | 16807920 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of DAB2IP mRNA" | 25554681 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of DAB2IP mRNA" | 25554681 |
D054328 | Proton Pump Inhibitors | Proton Pump Inhibitors results in decreased expression of DAB2IP mRNA | 25626140 |
D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of DAB2IP mRNA | 25895662 |
C017947 | sodium arsenite | sodium arsenite results in decreased methylation of DAB2IP gene | 25199682 |
D013629 | Tamoxifen | Tamoxifen results in increased expression of DAB2IP mRNA | 25123088 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of DAB2IP mRNA | 21570461 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of DAB2IP mRNA | 19933214 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of DAB2IP mRNA | 21215274 |
C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of DAB2IP mRNA" | 26179874 |
D014635 | Valproic Acid | Valproic Acid affects the expression of DAB2IP mRNA | 17292431|1796380 |
C025643 | vinclozolin | vinclozolin affects the expression of DAB2IP mRNA | 23034163 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005123 | death receptor binding | - | IPI | 15310755 |
GO:0005515 | protein binding | - | IPI | 12813029 17389591 19903888 20080667 |
GO:0017124 | SH3 domain binding | - | IDA | 19033661 19903888 |
GO:0019900 | kinase binding | - | IPI | 17389591 |
GO:0019901 | protein kinase binding | - | IDA | 18281285 |
GO:0019901 | protein kinase binding | - | IPI | 20080667 |
GO:0031434 | mitogen-activated protein kinase kinase binding | - | IPI | 17389591 |
GO:0031435 | mitogen-activated protein kinase kinase kinase binding | - | IPI | 12813029 |
GO:0032266 | phosphatidylinositol-3-phosphate binding | - | IDA | 19948740 |
GO:0035591 | signaling adaptor activity | - | IDA | 20080667 |
GO:0035662 | Toll-like receptor 4 binding | NOT | IDA | 19948740 |
GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding | - | IDA | 19903888 |
GO:0042802 | identical protein binding | - | IPI | 12813029 |
GO:0042803 | protein homodimerization activity | - | IPI | 12813029 |
GO:0043184 | vascular endothelial growth factor receptor 2 binding | - | IPI | 19033661 |
GO:0043548 | phosphatidylinositol 3-kinase binding | - | IDA | 19033661 |
GO:0044877 | protein-containing complex binding | - | IDA | 19903888 |
GO:0045296 | cadherin binding | - | HDA | 25468996 |
GO:0051721 | protein phosphatase 2A binding | - | IDA | 20080667 |
GO:0070273 | phosphatidylinositol-4-phosphate binding | - | IDA | 19948740 |
GO:0071889 | 14-3-3 protein binding | - | IDA | 17389591 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000122 | negative regulation of transcription by RNA polymerase II | - | IDA | 15310755 |
GO:0000122 | negative regulation of transcription by RNA polymerase II | - | IMP | 20154697 |
GO:0000165 | MAPK cascade | - | TAS | - |
GO:0000185 | activation of MAPKKK activity | - | IDA | 19903888 |
GO:0001525 | angiogenesis | - | IEA | - |
GO:0001933 | negative regulation of protein phosphorylation | - | IMP | 20080667 |
GO:0001933 | negative regulation of protein phosphorylation | - | ISS | - |
GO:0006954 | inflammatory response | - | IEA | - |
GO:0007049 | cell cycle | - | IEA | - |
GO:0007252 | I-kappaB phosphorylation | - | ISS | - |
GO:0007257 | activation of JUN kinase activity | - | IDA | 12813029 |
GO:0008285 | negative regulation of cell proliferation | - | IDA | 19903888 |
GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors | - | IMP | 19903888 |
GO:0010596 | negative regulation of endothelial cell migration | - | IMP | 19033661 |
GO:0010633 | negative regulation of epithelial cell migration | - | IMP | 20080667 |
GO:0010633 | negative regulation of epithelial cell migration | - | TAS | 20080667 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | - | IDA | 20154697 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | - | IMP | 20080667 |
GO:0010976 | positive regulation of neuron projection development | - | ISS | - |
GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling | - | IDA | 19903888 |
GO:0016525 | negative regulation of angiogenesis | - | IDA | 19033661 |
GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration | - | ISS | - |
GO:0021819 | layer formation in cerebral cortex | - | ISS | - |
GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | - | IMP | 19033661 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | - | IMP | 20154697 |
GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway | - | IDA | 19948740 |
GO:0034260 | negative regulation of GTPase activity | - | IMP | 20154697 |
GO:0034260 | negative regulation of GTPase activity | - | ISS | - |
GO:0034620 | cellular response to unfolded protein | - | TAS | 22013210 |
GO:0035148 | tube formation | - | IMP | 19033661 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | - | IDA | 19033661 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | - | ISS | - |
GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway | - | ISS | - |
GO:0038026 | reelin-mediated signaling pathway | - | IEA | - |
GO:0040008 | regulation of growth | - | IEA | - |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | - | ISS | 11812785 |
GO:0043065 | positive regulation of apoptotic process | - | IDA | 17389591 19903888 |
GO:0043087 | regulation of GTPase activity | - | ISS | - |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling | - | ISS | - |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling | - | IDA | 15310755 17389591 |
GO:0043254 | regulation of protein complex assembly | - | IDA | 19948740 |
GO:0043407 | negative regulation of MAP kinase activity | - | IDA | 12813029 |
GO:0043407 | negative regulation of MAP kinase activity | - | IMP | 20154697 |
GO:0043410 | positive regulation of MAPK cascade | - | IDA | 19903888 |
GO:0043497 | regulation of protein heterodimerization activity | - | IDA | 18281285 |
GO:0043507 | positive regulation of JUN kinase activity | - | IDA | 15310755 |
GO:0043547 | positive regulation of GTPase activity | - | IEA | - |
GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity | - | IDA | 19903888 |
GO:0044257 | cellular protein catabolic process | - | IDA | 17389591 |
GO:0045087 | innate immune response | - | IEA | - |
GO:0045732 | positive regulation of protein catabolic process | - | ISS | - |
GO:0045892 | negative regulation of transcription, DNA-templated | - | IMP | 20080667 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | - | IDA | 15310755 17389591 |
GO:0046330 | positive regulation of JNK cascade | - | IDA | 17389591 19903888 |
GO:0046580 | negative regulation of Ras protein signal transduction | - | IC | 20154697 |
GO:0048147 | negative regulation of fibroblast proliferation | - | ISS | - |
GO:0048812 | neuron projection morphogenesis | - | ISS | - |
GO:0050680 | negative regulation of epithelial cell proliferation | - | IMP | 20154697 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | - | ISS | 18281285 |
GO:0070317 | negative regulation of G0 to G1 transition | - | IDA | 19903888 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | - | IDA | 19903888 |
GO:0071158 | positive regulation of cell cycle arrest | - | IDA | 19903888 |
GO:0071222 | cellular response to lipopolysaccharide | - | IDA | 19948740 |
GO:0071347 | cellular response to interleukin-1 | - | IDA | 19948740 |
GO:0071356 | cellular response to tumor necrosis factor | - | IDA | 12813029 15310755 17389591 |
GO:0071364 | cellular response to epidermal growth factor stimulus | - | ISS | 11812785 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | - | IDA | 19903888 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | - | IMP | 20154697 |
GO:0071902 | positive regulation of protein serine/threonine kinase activity | - | IDA | 19903888 |
GO:0071902 | positive regulation of protein serine/threonine kinase activity | - | IMP | 20080667 |
GO:0072577 | endothelial cell apoptotic process | - | TAS | 19903888 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | - | IMP | 20080667 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | - | ISS | - |
GO:0090129 | positive regulation of synapse maturation | - | ISS | - |
GO:1900006 | positive regulation of dendrite development | - | ISS | - |
GO:1900744 | regulation of p38MAPK cascade | - | ISS | - |
GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway | - | ISS | - |
GO:1901800 | positive regulation of proteasomal protein catabolic process | - | IMP | 20080667 |
GO:1903363 | negative regulation of cellular protein catabolic process | - | IDA | 19903888 |
GO:1903896 | positive regulation of IRE1-mediated unfolded protein response | - | TAS | 22013210 |
GO:2001224 | positive regulation of neuron migration | - | ISS | - |
GO:2001235 | positive regulation of apoptotic signaling pathway | - | IDA | 19903888 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005737 | cytoplasm | - | IDA | 15310755 19948740 |
GO:0005829 | cytosol | - | TAS | - |
GO:0005886 | plasma membrane | - | IDA | 15310755 19948740 |
GO:0030139 | endocytic vesicle | - | IDA | 19948740 |
GO:0030424 | axon | - | ISS | - |
GO:0030425 | dendrite | - | IEA | - |
GO:0032809 | neuronal cell body membrane | - | ISS | - |
GO:0043025 | neuronal cell body | - | ISS | - |
GO:0044300 | cerebellar mossy fiber | - | ISS | - |
GO:0044301 | climbing fiber | - | ISS | - |
GO:1990032 | parallel fiber | - | ISS | - |
GO:1990597 | AIP1-IRE1 complex | - | IDA | 18281285 |
KEGG ID | KEGG Term |
---|
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-1643685 | Disease | TAS |
R-HSA-5658442 | Regulation of RAS by GAPs | TAS |
R-HSA-5663202 | Diseases of signal transduction | TAS |
R-HSA-5673001 | RAF/MAP kinase cascade | TAS |
R-HSA-5683057 | MAPK family signaling cascades | TAS |
R-HSA-5684996 | MAPK1/MAPK3 signaling | TAS |
R-HSA-6802949 | Signaling by RAS mutants | TAS |
R-HSA-6802957 | Oncogenic MAPK signaling | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
20622881 | Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. (2010 Aug) | Gretarsdottir S | Nat Genet |
28167353 | Genetic risk analysis of coronary artery disease in Pakistani subjects using a genetic risk score of 21 variants. (2017 Mar) | Shahid SU | Atherosclerosis |